Esmail El-Fakharany | Drug Delivery | Research Excellence Award

Published on by sciencefatherLeave a Comment on Esmail El-Fakharany | Drug Delivery | Research Excellence Award

Prof. Dr. Esmail El-Fakharany | Drug Delivery | Research Excellence Award

City of Scientific Research and Technological Applications | Egypt

Prof. Dr. Esmail El-Fakharany is a distinguished scientist affiliated with the Protein Research Department at the Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, where his work significantly advances biomedical and biotechnological research. He earned his Ph.D. in Microbiology with a minor specialization in biotechnology in 2012, following an M.Sc. in Microbiology with a focus on antiviral agents in 2009, both from the Faculty of Science, Al-Azhar University, Cairo. His academic foundation is further strengthened by a Diploma in Public Health Microbiology from the High Institute of Public Health, Alexandria University, and a B.Sc. in Microbiology with excellent distinction. Prof. Dr. El-Fakharany possesses extensive experience in immunology and immunoblotting, molecular biology, therapeutic protein and enzyme purification, antiviral and anticancer agent investigation, microbiological techniques, and tissue culture and cell line maintenance. His primary research interests center on antiviral proteins, recombinant and natural bioactive molecules, therapeutic protein engineering, immunological applications, and biotechnology-driven drug development. Through sustained scientific contributions, he has received professional recognition for excellence in microbiology and biotechnology research. Overall, his work continues to play a vital role in translating fundamental microbiological insights into innovative therapeutic strategies, contributing meaningfully to global health and applied life sciences.

View Google Scholar Profile

Featured Publications

Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study

Virology Journal, 2013, Vol. 10(1), Article 199

Oyster mushroom laccase inhibits hepatitis C virus entry into peripheral blood cells and hepatoma cells

Protein & Peptide Letters, 2010, Vol. 17(8), pp. 1031–1039

Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and HeLa cell lines

Hepatitis Monthly, 2011, Vol. 11(9)

Potential lactoferrin activity against pathogenic viruses

Comptes Rendus Biologies, 2014, Vol. 337(10), pp. 581–595

Poly(vinyl alcohol)–hyaluronic acid membranes for wound dressing applications: synthesis and in vitro bio-evaluations

Journal of the Brazilian Chemical Society, 2015, Vol. 26(7), pp. 1466–1474

Xiang Wu | Medical Biomaterials | Research Excellence Award

Published on by sciencefatherLeave a Comment on Xiang Wu | Medical Biomaterials | Research Excellence Award

Dr. Xiang Wu | Medical Biomaterials | Research Excellence Award

Ningbo University | China

Dr. Xiang Wu is a dedicated medical researcher and clinician currently serving at Ningbo Medical Center Li Huili Hospital, Health Science Center, Ningbo University, where he actively contributes to interdisciplinary biomedical research. With a strong academic foundation in medical sciences and biomaterials, his education and professional training have enabled him to bridge clinical needs with engineering-driven solutions. His experience spans hospital-based research and university-level scientific collaboration, focusing on translating laboratory innovations into practical medical applications. Dr. Wu’s primary research interests include functional hydrogels for tissue adhesion, hemostasis, postoperative repair, and advanced biomaterials such as bone and joint materials, adhesive systems, and Janus patches. In parallel, he investigates molecular regulatory mechanisms involving lncRNA and circRNA in cancers, particularly pancreatic and bladder cancer, highlighting his integrative approach that combines materials science with molecular medicine. Since 2020, his scholarly contributions have gained notable academic recognition, reflected in a strong citation record and h-index, underscoring the impact of his research on addressing clinical treatment challenges. His work aligns closely with modern translational medicine, emphasizing innovation, clinical relevance, and interdisciplinary collaboration. In conclusion, Dr. Wu represents a new generation of clinician-scientists whose research advances both biomedical materials and molecular oncology, contributing meaningfully to improved therapeutic strategies and future medical technologies.

Profiles: Orcid | Google Scholar

Featured Publications

 

Yangyang Han | Nanomaterials | Research Excellence Award

Published on by sciencefatherLeave a Comment on Yangyang Han | Nanomaterials | Research Excellence Award

Prof. Yangyang Han | Nanomaterials | Research Excellence Award

Shandong Second Medical University, China

Prof. Yangyang Han is a distinguished scholar and influential educator whose work spans biochemistry, molecular biology, and biomechanics. He holds a Ph.D. and has built a strong academic foundation that supports his role as a Professor and Master’s Supervisor. Over the years, he has served in several notable capacities, including Associate Professor, Lecturer, and Senior Visiting Scholar at the Institute of Mechanics, Chinese Academy of Sciences, where he deepened his expertise in molecular mechanisms and biomechanical processes. His professional journey includes leadership as Director of the Molecular Biology Teaching and Research Section and service as a Review Expert for the National Natural Science Foundation of China, reflecting his credibility in scientific evaluation and research guidance. As Leader of the Youth Innovation Team of Shandong Provincial Institutions of Higher Education and a Director within the Shandong Society of Biochemistry and Molecular Biology, he continues to foster scientific development and interdisciplinary collaboration. His research interests focus on molecular regulation, cellular biomechanics, and biomedical innovation, contributing to impactful advancements in the field. With recognition for his academic leadership and scientific service, Prof. Han remains committed to driving research excellence, nurturing emerging scholars, and advancing knowledge in life sciences.

Profiles: Scopus | Orcid

Featured Publications

Bai, L., Qian, X., Zhang, H., Yuan, Y., Cui, X., Cheng, M., & Han, Y. (2025). Plectin, a novel regulator in migration, invasion and adhesion of ovarian cancer. Cell & Bioscience. https://doi.org/10.1186/s13578-025-01349-2

Han, Y. (2020). RNA-seq reveals the diverse effects of substrate stiffness on epidermal ovarian cancer cells. Aging. https://doi.org/10.18632/aging.103906

Han, Y. (2020). Elevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia. Cell Death Discovery. https://doi.org/10.1038/s41420-020-0269-0

 

Weikai Zhang | Drug Discovery | Research Excellence Award

Published on by sciencefatherLeave a Comment on Weikai Zhang | Drug Discovery | Research Excellence Award

Dr. Weikai Zhang | Drug Discovery | Research Excellence Award

Luoyang Polytechnic, China

Dr. Weikai Zhang is a dedicated biomedical engineering researcher whose work centers on advancing single-cell technologies for improved antibody discovery and biomedical applications. He earned his PhD in Biomedical Engineering from the School of Life Science at the Beijing Institute of Technology, preceded by a Master’s degree from Henan University of Science and Technology and a Bachelor’s degree in Biotechnology from Xinyang Agricultural College. His academic journey included extensive joint master’s and doctoral research at the National Center for Nanoscience and Technology, where he investigated nanobiological effects and safety. Earlier in his career, he contributed as a technician in the Antibody Engineering Laboratory at the National Protein Science Center in Beijing, gaining foundational expertise in protein science and antibody development. Currently, he serves as a Lecturer and Deputy Director of the Key Engineering Technology Research Center for Immune Technology Biological Materials Preparation in Henan Province. His research focuses on designing and developing microfluidic chips for single-cell analysis, improving throughput and screening efficiency, and enhancing diagnostic and therapeutic antibody development. Recognized for his scientific contributions, he has received multiple honors, including youth talent awards and innovation recognitions. Dr. Zhang continues to advance impactful research in biomedical engineering and single-cell technology.

Profile: Orcid

Featured Publications

Zhang, W., Li, Q., Jia, F., Hu, Z., & Wei, Z. (2021). “A microfluidic chip for screening and sequencing of monoclonal antibody at a single-cell level.” Analytical Chemistry. https://doi.org/10.1021/acs.analchem.1c00918

 

Radwa Mahmoud | Biotechnology | Excellence in Research Award

Published on by sciencefatherLeave a Comment on Radwa Mahmoud | Biotechnology | Excellence in Research Award

Ms. Radwa Mahmoud | Biotechnology | Excellence in Research Award

Biotechnology Department, Faculty of Science, Cairo University, Egypt

Ms. Radwa Mahmoud is an emerging biotechnology researcher with strong expertise in cancer therapeutics, molecular diagnostics, and nanoparticle biosynthesis. She is currently pursuing a Master’s degree in Biotechnology at Cairo University, where she previously completed her Bachelor’s degree with distinction, ranking among the top students. Her research interests span breast cancer treatment using scorpion-venom-derived peptides, CRISPR-based microbiome engineering, antimicrobial peptides, and the biomedical applications of nanomaterials. Radwa has extensive hands-on experience in wet-lab experimentation, diagnostic assay design, cytotoxicity analysis, molecular cloning, protein purification, and computational modeling. She has led multidisciplinary research projects focused on early breast cancer detection and innovative therapeutic models, earning competitive funding support from the Science and Technology Development Fund (STDF) and winning awards such as Best Poster at SOLE and a Silver Medal at the international iGEM competition. Her professional experience includes roles in pharmaceutical research and development, molecular biology laboratories, and academic teaching support. Radwa’s growing publication record and contributions to translational research highlight her commitment to advancing oncology, biotechnology innovation, and therapeutic discovery. She aims to continue developing impactful scientific solutions addressing global health challenges.

Profiles: Scopus | Orcid

Featured Publications

Amen, R.A. (2024). “Harnessing plant extracts for skin health and dermatological care: herbal wonders green solutions” in Herbal Wonders Green Solutions.

Amen, R.A. (2024). “Therapeutic potential and characteristics of Smp43 peptide (scorpion venom) and its interaction with cellular signaling pathways: a review” in Review.

Amen, R.A. (2024). “Exploring the potential of natural compounds in cancer treatment: a review” in Review.

Amen, R.A. (2024). “Coinfection of schistosomiasis and hepatitis C in Egypt: challenges and possible management strategies” in Review.

Amen, R.A. (2024). “Biosynthesis of silver, copper, and their bi-metallic nanocomposites by Staphylococcus aureus: their antimicrobial, anticancer activity, and cytotoxicity effect” in Journal Article.

Amen, R.A. (2023). “COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic” in Review.

Amen, R.A. (2022). “Pharmacological properties of 4′, 5, 7-trihydroxyflavone (apigenin) and its impact on cell signaling pathways” in Review.